Emtricitabine/tenofovir/rilpivirine regulatory update

Gilead submitted an NDA to FDA for a fixed-dose combination of rilpivirine and Truvada emtricitabine/tenofovir to treat HIV infection in adults. Johnson & Johnson partnered with Gilead last year to d...